Results 81 to 90 of about 28,538 (266)
Clinical characteristics of cutaneous vasculitis secondary to systemic lupus erythematosus [PDF]
Ye Zhizho +5 more
openalex +1 more source
ABSTRACT Background Prurigo nodularis patients face a significant burden of comorbidities, necessitating a comprehensive approach to care. We aimed to explore the association between prurigo nodularis, its comorbid conditions, and healthcare usage patterns.
Yuliya Valdman‐Grinshpoun +4 more
wiley +1 more source
Lupus Erythematosus: Cutaneous Manifestations and Treatment
Cutaneous lupus erythematosus (CLE) includes a broad range of dermatologic manifestations, which may or may not be associated with systemic manifestations. Specific CLE - defined by the presence of an interface dermatitis on histopathological evaluation -
Francisca Alves, Margarida Gonçalo
doaj +1 more source
Rapid onset of systemic lupus erythematosus with rarely observed cutaneous lesions [PDF]
Martyna Skręta-Śliwińska +4 more
openalex +1 more source
Undermined and Overlooked: A Diagnostic Challenge in the Gluteal Cleft
JEADV Clinical Practice, EarlyView.
G. E. Beraja, Y. Dalia, J. A. Jaller
wiley +1 more source
Effect of Belimumab on the Cutaneous Manifestations of Patients With Lupus Erythematosus
ABSTRACT Background The aim was to assess the long‐term effect of belimumab on the cutaneous manifestations of patients with systemic lupus erythematosus (SLE). Methods The retrospective analysis included 29 patients with SLE. Cutaneous disease activity was assessed using the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) and the
Diana Schellin +5 more
wiley +1 more source
Cutaneous Lupus Erythematosus: Current Treatment Options [PDF]
J.K. Presto, Victoria P. Werth
openalex +1 more source
Blaschkoid Facial Lesion in an Adult Woman
JEADV Clinical Practice, EarlyView.
João Teixeira +4 more
wiley +1 more source
Tissue Resident Memory Cells: Friend or Foe?
Tissue‐resident memory T cells (TRM cells) are specialised immune cells in barrier tissues like the lungs, skin and gut, providing rapid host defence and tumour surveillance. Their retention and differentiation are regulated by molecules such as CD69, CD103 and TGF‐β. Dysregulation of TRM cells can lead to chronic activation, driving conditions such as
Chidimma F. Chude +2 more
wiley +1 more source

